Mr. Jay Kaushik Narasimhan joined MMC Pharmaceuticals as Managing Director on 23 August 2026. He is a pharmaceutical business leader and serial entrepreneur with over three decades of experience in building healthcare businesses and brands.
He began his career in 1991 as a Medical Representative at Merind, a Tata company, and subsequently held business-building roles at Novartis, Ogilvy and Dr. Reddy’s Laboratories.
In 2005, he co-founded Curatio Healthcare, helping establish dermatology brands such as Tedibar, Atogla, Spoo and Fash. He later founded Inzpera, a pediatric nutrition venture with the House of Tatas as co-investors, which was acquired by Cipla in 2025.
His leadership combines a deep understanding of doctors, patients and field teams with expertise in brand development and business growth. At MMC Pharmaceuticals, he oversees day-to-day operations and leads the company’s growth and expansion plans.






























